Antonio Tajani at EU Confirmation Hearing European industry should see the devel...
Antonio Gaudi Gods Architect part 6 of 7 BBC Documentary - Visions Of Space - 20...
Antonio Gaudi Gods Architect part 7 of 7 BBC Documentary - Visions Of Space - 20...
Antonio Gaudi Gods Architect part 5 of 7 BBC Documentary - Visions Of Space - 20...
Antonio Gaudi Gods Architect part 4 of 7 BBC Documentary - Visions Of Space - 20...
ecancertv |
(0) (0 Votes)
|
Views: (2222) Date: (07-04-10) Time: (00:05:25) |
Description: Early results of the AZURE (Adjuvant Zoledronic Acid to Reduce Recurrence) trial suggest that zoledronic acid may have antitumor properties when combined with chemotherapy. Treatment was linked with a reduction in tumor size (20.5 mm vs. 30 mm), an increase in the complete response rate (10.9 percent vs. 5.8 percent) and a decrease in the number of patients requiring mastectomy (65.3 percent vs. 77.9 percent). Dr Robert Coleman, speaking at the 2008 San Antonio Breast Cancer Symposium.